Task: Answer the multiple-choice question.
Question: Which compound exhibits a -30.425% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a CCc1nc(Nc2ccccc2)c2nnn(Cc3ccccc3)c2n1
b C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43O)[C@@H]1CCC2=O
c Cc1cc(C)cc(SCc2noc(C(=O)NCCCN3CCOCC3)c2C(=O)NCCCN2CCOCC2)c1
d COC(=O)C1=C(c2ccc(C(C)=O)cc2)C[C@@H]2CC[C@H]1N2C(=O)NCCOc1ccccc1Cl
Answer: c. Cc1cc(C)cc(SCc2noc(C(=O)NCCCN3CCOCC3)c2C(=O)NCCCN2CCOCC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)cc(SCc2noc(C(=O)NCCCN3CCOCC3)c2C(=O)NCCCN2CCOCC2)c1
Cc1cc(C)cc(SCc2noc(C(=O)NCCCN3CCOCC3)c2C(=O)NCCCN2CCOCC2)c1
3-[(3,5-dimethylphenyl)sulfanylmethyl]-4-N,5-N-bis(3-morpholin-4-ylpropyl)-1,2-oxazole-4,5-dicarboxamide